EMJ Diabetes 10 [Supplement 1] 2022
With the incidence of diabetes rising annually across the globe to an estimated 537 million adults, healthcare expenditure is also rising. To gain a wide perspective of diabetes care, EMJ discussed a range of pertinent topics with four international experts.
1st August 2022
The Association of Serum Progesterone Levels on Day of Oocyte Retrieval with Pregnancy Outcome
To establish the level of serum progesterone (P4) on the day of oocyte retrieval beyond which it can affect the outcome of in vitro fertilisation (IVF), and to further establish the incidence of serum P4 rise in an agonist and antagonist cycle.
29th July 2022
Unpacking the Immune System
This week, Peter Arkwright, Senior Lecturer in Paediatric Allergy and Immunology, Lydia Becker Institute of Immunology and Inflammation, University of Manchester, UK, joins Evgenia to speak about the prevalence of allergy and the challenges surrounding immune disease in children.
25th July 2022
Next Step in Incretin-Based Therapy: From Single to Dual Agonism
The incretin effect, an augmented prandial insulin response, is mediated mostly by the hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), which are released from the intestines after meals.